Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers (EJNMMI Research, (2025), 15, 1, (67), 10.1186/s13550-025-01258-y)
Publication date
2025-09-02
Authors
Houvast, Ruben D.
Sier, Vincent Q.
van Duijvenvoorde, Maurice
Baart, Victor M.
Schomann, Timo
Chua, Jia Xin
Vankemmelbeke, Mireille
Durrant, Lindy G.
Krijgsman, D
de Heer, Pieter
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by
Abstract
Following discussion between the authors and the journal, the authorship of the published article has been updated by moving Dr Cornelis F. M. Sier from the Acknowledgements to the authorship list (as the final author in the list). The reason for this post-publication correction is to acknowledge Dr Sier’s role as a primary supervisor from the early stages of the research presented in the manuscript.
Keywords
Radiology Nuclear Medicine and imaging
Citation
Houvast, R D, Sier, V Q, van Duijvenvoorde, M, Baart, V M, Schomann, T, Chua, J X, Vankemmelbeke, M, Durrant, L G, Krijgsman, D, de Heer, P, Hassing, G J, Mieog, J S D, Crobach, A S L P, Burggraaf, J, Kuppen, P J K, Vahrmeijer, A L & Sier, C F M 2025, 'Correction : Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers (EJNMMI Research, (2025), 15, 1, (67), 10.1186/s13550-025-01258-y)', EJNMMI Research, vol. 15, no. 1, 117. https://doi.org/10.1186/s13550-025-01308-5